Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors

It has been indicated that proton pump inhibitor (PPI) use is associated with a loss of the anti-fracture efficacy of alendronate (AD). However, there are few prospective studies that have investigated the efficacy of AD on lumbar bone mineral density (BMD) in osteoporotic patients who are using PPI...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Biomed Rep
Main Authors: Asaoka, Daisuke, Nagahara, Akihito, Hojo, Mariko, Matsumoto, Kenshi, Ueyama, Hiroya, Matsumoto, Kohei, Izumi, Kentaro, Takeda, Tsutomu, Komori, Hiroyuki, Akazawa, Yoichi, Shimada, Yuji, Osada, Taro, Watanabe, Sumio
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2016
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950806/
https://ncbi.nlm.nih.gov/pubmed/27446535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.710
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים